CompaniesInvestorsPeople
Home
Loading

aVenture is in Beta: research coverage is expanding as we build, so please independently verify key details before making investment decisions.

aVenture is in Beta: research coverage is expanding as we build, so please independently verify key details before making investment decisions.

Get in Touch

  • Contact

  • Request a Demo

  • Request Data Updates

  • Add a Company

Research

  • Companies

  • Investors

  • People

aVenture

  • Download App

  • Pricing

Download the aVenture Research beta for iOS and iPadOSDownload aVenture Research on the Mac App Store

Resources

  • Documentation

  • Use Cases

  • CLI

  • MCP

  • Feature Requests

  • Sitemap

Member

Backed by

Ask AI about aVenture

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy · Terms of Service

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading
Home›
Companies›
Umami Bioworks
Umami Bioworks

Umami Bioworks

Umami Bioworks cultivates seafood and marine ingredients from fish cells on its AI-driven ALKEMYST platform for endangered species.

Operating headquarters
Singapore, SG🇸🇬
Founded
2020
Overview
M & A
Compare
Employees
News
Library

Umami Bioworks applies cell cultivation to seafood species that are endangered, threatened, or protected and difficult to farm, from Japanese eel to bluefin tuna. Its ALKEMYST platform pairs machine learning with stem cell biology and automated bioprocessing to grow fish cells into seafood and marine ingredients for food, cosmetics, and nutrition buyers.

Where conventional supply depends on wild capture and aquaculture of struggling stocks, Umami Bioworks offers seafood producers its cultivation system as production infrastructure rather than a single finished product. The company's position rests on the species it targets, the automation of its platform, and partnerships that span research institutes and food producers.

Umami Bioworks - M & A Snapshot

Open M & A
  • Shiok Meats

    Acquired by Umami Bioworks • Undisclosed • Mar 12, 2024

Umami Bioworks - Similar Companies

Cook Biotech logo

Cook Biotech

Nestlé Health Science logo

Nestlé Health Science

Ubee Interactive logo

Ubee Interactive

Vibrant Aging Insider logo

Vibrant Aging Insider

Uptempo logo

Uptempo

uptempo.io

Symx.ai logo

Symx.ai

symx.ai

Gaia logo

Gaia

gaiacompany.io

Umami Bioworks - Quick Facts

Who are Umami Bioworks' competitors?

Companies similar to Umami Bioworks include Cook Biotech, Nestlé Health Science, Ubee Interactive and Vibrant Aging Insider.

When was Umami Bioworks founded?

Umami Bioworks was founded in 2020.

Where is Umami Bioworks' headquarters located?

Umami Bioworks' headquarters is located in Singapore, SG.

Umami Bioworks - Classification

Industry
  • Food Production
Technology
  • Cell Line Development